These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
122 related items for PubMed ID: 2062836
1. Potent cytodifferentiating agents related to hexamethylenebisacetamide. Breslow R, Jursic B, Yan ZF, Friedman E, Leng L, Ngo L, Rifkind RA, Marks PA. Proc Natl Acad Sci U S A; 1991 Jul 01; 88(13):5542-6. PubMed ID: 2062836 [Abstract] [Full Text] [Related]
2. Second generation hybrid polar compounds are potent inducers of transformed cell differentiation. Richon VM, Webb Y, Merger R, Sheppard T, Jursic B, Ngo L, Civoli F, Breslow R, Rifkind RA, Marks PA. Proc Natl Acad Sci U S A; 1996 Jun 11; 93(12):5705-8. PubMed ID: 8650156 [Abstract] [Full Text] [Related]
3. A new group of potent inducers of differentiation in murine erythroleukemia cells. Reuben RC, Wife RL, Breslow R, Rifkind RA, Marks PA. Proc Natl Acad Sci U S A; 1976 Mar 11; 73(3):862-6. PubMed ID: 1062798 [Abstract] [Full Text] [Related]
4. Inducers of erythroleukemic differentiation. Relationship of structure to activity among planar-polar compounds. Reuben RC, Khanna PL, Gazitt Y, Breslow R, Rifkind RA, Marks PA. J Biol Chem; 1978 Jun 25; 253(12):4214-8. PubMed ID: 275252 [Abstract] [Full Text] [Related]
5. Vincristine-resistant erythroleukemia cell line has marked increased sensitivity to hexamethylenebisacetamide-induced differentiation. Melloni E, Pontremoli S, Damiani G, Viotti P, Weich N, Rifkind RA, Marks PA. Proc Natl Acad Sci U S A; 1988 Jun 25; 85(11):3835-9. PubMed ID: 3163801 [Abstract] [Full Text] [Related]
6. Bis-pyrrolyl-tetrazolyl derivatives as hybrid polar compounds: A case of lipophilic functional bioisosterism with bis-acetamides. Chatzopoulou M, Bonovolias ID, Nicolaou I, Demopoulos VJ, Vizirianakis IS, Tsiftsoglou AS. Eur J Med Chem; 2012 Apr 25; 50():75-80. PubMed ID: 22341896 [Abstract] [Full Text] [Related]
7. Differentiation inducers modulate cytokine signaling pathways in a murine erythroleukemia cell line. Yamashita T, Wakao H, Miyajima A, Asano S. Cancer Res; 1998 Feb 01; 58(3):556-61. PubMed ID: 9458105 [Abstract] [Full Text] [Related]
8. New designed HMBA agents as inducers of erythroleukemia cell differentiation. Wang H, Zhang S, Zhou J, Zhang J. Chin Med Sci J; 2002 Mar 01; 17(1):27-31. PubMed ID: 12894881 [Abstract] [Full Text] [Related]
9. Potential antitumor agents. 23.(1) Cytotoxic and differentiating activity of compounds related to hexamethylenebisacetamide. Andreani A, Rambaldi M, Locatelli A, Andreani F, Lollini PL, Nanni P, Bossa R, Galatulas I. Farmaco; 1993 Nov 01; 48(11):1503-13. PubMed ID: 8110363 [Abstract] [Full Text] [Related]
10. Hexamethylenebisacetamide-induced erythroleukemia cell differentiation involves modulation of events required for cell cycle progression through G1. Kiyokawa H, Richon VM, Venta-Perez G, Rifkind RA, Marks PA. Proc Natl Acad Sci U S A; 1993 Jul 15; 90(14):6746-50. PubMed ID: 8341693 [Abstract] [Full Text] [Related]
11. Comparative study of two groups of inducers of Friend erythroleukemia cell differentiation in a chemically defined medium. Gazitt Y. Cancer Res; 1981 Mar 15; 41(3):1184-6. PubMed ID: 6936075 [Abstract] [Full Text] [Related]
12. Polar/apolar chemical inducers of differentiation of transformed cells: strategies to improve therapeutic potential. Marks PA, Breslow R, Rifkind RA, Ngo L, Singh R. Proc Natl Acad Sci U S A; 1989 Aug 15; 86(16):6358-62. PubMed ID: 2762329 [Abstract] [Full Text] [Related]
13. A transient dephosphorylation of JAK1 and JAK2 characterises the early-phase response of murine erythroleukemia cells to the differentiation inducer hexamethylenebisacetamide. Arcangeli A, Fontana L, Crociani O, Cherubini A, Hofmann G, Piccini E, Polvani S, D'Amico M, Carlà M, Olivotto M. Leukemia; 2000 Dec 15; 14(12):2112-7. PubMed ID: 11187900 [Abstract] [Full Text] [Related]
14. Ureido derivatives of pyridine: a new class of inducers of murine erythroleukemia cell differentiation. Pappas IS, Niopas I, Tsiftsoglou AS. Anticancer Drug Des; 1992 Apr 15; 7(2):153-61. PubMed ID: 1575888 [Abstract] [Full Text] [Related]
15. Nuclear inositol lipids in Friend erythroleukemia cells. Changes related to differentiation induced by hexamethylenebisacetamide. Capitani S, Mazzoni M, Bertagnolo V, Previati M, Daddona A, Ricci D, Manzoli FA. Cell Biol Int Rep; 1990 Sep 15; 14(9):783-95. PubMed ID: 2177679 [Abstract] [Full Text] [Related]
16. Cytodifferentiating agents affect the replication of herpes simplex virus type 1 in the absence of functional VP16. Preston CM, McFarlane M. Virology; 1998 Sep 30; 249(2):418-26. PubMed ID: 9791032 [Abstract] [Full Text] [Related]
17. Differentiation of erythroleukemia cells in vitro: properties of chemical inducers. Preisler HD, Lyman G. Cell Differ; 1975 Jun 30; 4(3):179-85. PubMed ID: 1056810 [Abstract] [Full Text] [Related]
18. Differentiation of murine erythroleukemia cells by hexamethylenebisacetamide involves secretion and binding to membranes of a differentiation enhancing factor. Sparatore B, Patrone M, Passalacqua M, Melloni E, Pontremoli S. Biochem Biophys Res Commun; 1991 Aug 30; 179(1):153-60. PubMed ID: 1883347 [Abstract] [Full Text] [Related]
19. Effect of hexamethylene bisacetamide on the commitment to differentiation of murine erythroleukemia cells. Fibach E, Reuben RC, Rifkind RA, Marks PA. Cancer Res; 1977 Feb 30; 37(2):440-4. PubMed ID: 264411 [Abstract] [Full Text] [Related]
20. Effects of trichostatins on differentiation of murine erythroleukemia cells. Yoshida M, Nomura S, Beppu T. Cancer Res; 1987 Jul 15; 47(14):3688-91. PubMed ID: 2439196 [Abstract] [Full Text] [Related] Page: [Next] [New Search]